MeiraGTx Holdings (MGTX) Payables (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Payables came in at $34.7 million in Q4 2025, up 47.18% YoY from $23.6 million in Q4 2024, and down 63.69% on a QoQ basis from $95.6 million in Q3 2025.
MeiraGTx Holdings (MGTX) Payables (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Payables data on file, last reported at $34.7 million in Q4 2025.
- Quarterly Payables rose 47.18% year-over-year to $34.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34.7 million (up 47.18% YoY) and the FY2025 annual result came in at $34.7 million, up 47.18% from the prior year.
- Payables fell to $34.7 million in Q4 2025, from $95.6 million in the prior quarter.
- In the past five years, Payables ranged from a high of $95.6 million in Q3 2025 to a low of $7.9 million in Q1 2021.
- A 5-year average of $24.4 million and a median of $21.0 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2021 — Payables surged 276.91% — and 2024, when it fell 28.67%.
- Tracing MGTX's Payables over 5 years: stood at $15.3 million in 2021, then rose by 8.26% to $16.6 million in 2022, then decreased by 3.45% to $16.0 million in 2023, then soared by 47.03% to $23.6 million in 2024, then soared by 47.18% to $34.7 million in 2025.
- The last three Payables figures came in at $34.7 million (Q4 2025), $95.6 million (Q3 2025), and $25.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - | 34.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 34.71 Mn |
| Sep 30, 2025 | 95.59 Mn |
| Jun 30, 2025 | 25.59 Mn |
| Mar 31, 2025 | 20.29 Mn |
| Dec 31, 2024 | 23.59 Mn |
| Sep 30, 2024 | 29.50 Mn |
| Jun 30, 2024 | 21.40 Mn |
| Mar 31, 2024 | 21.22 Mn |
| Dec 31, 2023 | 16.04 Mn |
| Sep 30, 2023 | 20.77 Mn |
| Jun 30, 2023 | 28.50 Mn |
| Mar 31, 2023 | 29.76 Mn |
| Dec 31, 2022 | 16.62 Mn |
| Sep 30, 2022 | 21.69 Mn |
| Jun 30, 2022 | 18.11 Mn |
| Mar 31, 2022 | 18.50 Mn |
| Dec 31, 2021 | 15.35 Mn |
| Sep 30, 2021 | 11.42 Mn |
| Jun 30, 2021 | 11.64 Mn |
| Mar 31, 2021 | 7.90 Mn |